The presentation videos and slides for speakers lectures are provided below, given that they have granted us permission to do so.
Topics
Meeting category
Date(s)
16 Dec 2022
Meeting type
Virtual Meeting
Organizer
Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition
Related Enduring Materials
Enduring Materials
Session 1: Models of Delivery - 14:05
Marta Boffito, MD, PhD, FRCP, MBA
Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
14:05
Pharmacological Considerations: Injections, Implants, Microneedles
14:20
What Is in the Pipeline? (Models of Delivery)
Chelsea and Westminster Hospital NHS Foundation Trust; Imperial College London; United Kingdom
14:40
Implementation Considerations
UNAIDS Regional Office for Asia and the Pacific, Thailand and the Global HIV, Hepatitis and STIs Programme, World Health Organisation, Switzerland
Debate: We Do Not Need Different Strategies to Implement LA Treatment and LA PrEP - 15:10
15:20
PRO
15:30
CON
Session 2: Innovation in HIV Drugs - 16:35
Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipHIV
16:35
What is the Pipeline? (Drugs)
16:55
Clinical Considerations: What Have We Learned?
MRC/UVRI-LSHTM Uganda Research Unit / Brighton and Sussex Medical School, United Kingdom / Uganda
Roundtable: Focus On Access and Advocacy, Including PrEP, Treatment, and User Perspective - 17:20
17:20
Introduction: Access and Advocacy
General
What's New
The advent of the COVID-19 pandemic has drastically changed the delivery of HIV care, but there is more on the horizon. New compounds with diverse modes of action and novel formulations have the potential to revolutionize HIV service delivery even more, as these may allow longer dosing schedules, increase adherence and improve cost-efficacy. Therefore, there is a continuous need for medical education on new (long-acting) antiretroviral therapies (ART), novel formulations, and devices to provide the best care. In contrast to existing educational activities that focus on approved or late-stage clinical data on ART, this program offers a platform entirely dedicated to HIV preclinical and early clinical development. This platform considered regional differences in health care systems, with a focus on the Asia-Pacific region.
Welcome
The Innovations in HIV Therapeutics - Asia Pacific Edition took place as a virtual meeting on 16 December 2022.
As the pipeline of HIV drugs continues to evolve and novel formulations and devices are on the horizon, the Innovation in HIV Therapeutics meeting provided a scientific program that keeps HIV-treating clinicians, pharmacologists, and virologists updated on the latest data present in preclinical and early clinical development. New formulations, novel compounds, and their modes of action were presented, as well as their pharmacological properties, potential drug-drug interactions, and possible toxicities.
This meeting was presented as a one-day program accounting for the unique regional differences present in the Asia Pacific region.
Program Director
General Information
Who Should Attend?
- HIV-treating Clinicians
- Pharmacologists
- Virologists
- Researchers
- Pharmacologists
- Virologists
- Researchers
Meeting Objectives
This meeting aims to:
- Update clinicians on the latest therapeutics and innovations in HIV (long-acting) therapeutics;
- Understand pharmacological properties, safety profile, and resistance of new long-acting ART;
- Evaluate how innovations in treatments can impact people living with HIV.
- Update clinicians on the latest therapeutics and innovations in HIV (long-acting) therapeutics;
- Understand pharmacological properties, safety profile, and resistance of new long-acting ART;
- Evaluate how innovations in treatments can impact people living with HIV.
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the innovations in HIV treatments, novel formulations and devices on the horizon;
- Define pharmacological properties, potential drug-drug interactions, possible toxicities, and resistance profiles of novel drugs;
- Reflect on the implementation of novel HIV (long-acting) therapeutics in various populations and settings.
- Describe the innovations in HIV treatments, novel formulations and devices on the horizon;
- Define pharmacological properties, potential drug-drug interactions, possible toxicities, and resistance profiles of novel drugs;
- Reflect on the implementation of novel HIV (long-acting) therapeutics in various populations and settings.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the meeting is English.
Enduring Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Program Director
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Acknowledgement
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in Innovations and HIV Treatment.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Olivia Zhang at olivia.zhang@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Digital and printed advertising opportunities
- Social media shout-outs
*Subject to the support level.
Endorsers
The Innovations in HIV Therapeutics - Asia Pacific Edition is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this forum.
If you would like your organization to endorse this forum, please contact Claudia Narvaez at Claudia.Narvaez@amededu.com
Accreditation
Innovations in HIV Therapeutics - Asia Pacific Edition is accredited by the following societies. To claim the CME points, members of the societies must log on to the virtual congress portal and attend the full sessions. Additional information such as membership number or license number might be required after the event.
Hong Kong Academy of Medicine (HKAM)
Innovations in HIV Therapeutics - Asia Pacific Edition is accredited by the Hong Kong Academy of Medicine (HKAM) up to 3 credits. To claim the CME points, members of the HKAM must log on to the virtual congress portal and attend the full sessions.
|
College |
16 December |
|
Physicians |
3 CME Points |
Infectious Diseases Association of Thailand (IDAT)
Innovations in HIV Therapeutics - Asia Pacific Edition is accredited by the Infectious Diseases Association of Thailand (IDAT) up to 3.25 credits. To claim the CME points, members of the IDAT must log on to the virtual congress portal and attend the full sessions.
|
Session 1 |
Debate |
Session 2 |
|
1.25 CME Points |
1 CME Points |
2 CME Points |
Language
Related Programs
